CIK 0001933414
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 841966887
- Phone
- +1 888-378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,209,843
- in 4 filings, $2.2M under 10b5-1 plans
Net −$5,209,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-17 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −417 | $25.65 | $11K | 76,140 |
| 2026-03-17 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −417 | 5,000 | ||
| 2026-03-13 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +3,542 | $10.20 | $36K | 86,031 |
| 2026-03-13 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +4,167 | $14.25 | $59K | 90,198 |
| 2026-03-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −10,726 | $25.91 | $278K | 79,472 |
| 2026-03-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −3,079 | $27.37 | $84K | 76,393 |
| 2026-03-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −253 | $27.82 | $7K | 76,140 |
| 2026-03-13 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −3,542 | 123,959 | ||
| 2026-03-13 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −4,167 | 95,834 | ||
| 2026-03-12 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +6,348 | $1.08 | $7K | 88,837 |
| 2026-03-12 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −6,348 | $27.37 | $174K | 82,489 |
| 2026-03-12 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −6,348 | 25,395 | ||
| 2026-03-09 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +2,171 | $16.00 | $35K | 84,660 |
| 2026-03-09 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −2,171 | $26.84 | $58K | 82,489 |
| 2026-03-09 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −2,171 | 23,876 | ||
| 2026-02-19 | Rodman David Malcom Chief Medical Officer | Grant or award | +38,400 | 82,489 | ||
| 2026-02-19 | Rodman David Malcom Chief Medical Officer | Grant or award · Stock Option | +51,300 | 51,300 | ||
| 2026-02-17 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +417 | $15.44 | $6K | 44,506 |
| 2026-02-17 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −417 | $27.59 | $12K | 44,089 |
| 2026-02-17 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −417 | 5,417 |
Page 4 of 12 · 239 trades